Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients

AIM: To investigate the clinical utility of serum annexin A2 (ANXA2) as a diagnostic marker for early hepatocellular carcinoma (HCC). METHODS: This study was performed in HCC Clinic of Ain Shams University Hospitals, Cairo, Egypt and included: Group 1: Fifty patients with early stage HCC (Barcelona...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Hepatol
Main Authors: Shaker, Mohamed K, Abdel Fattah, Hanzada I, Sabbour, Ghada S, Montasser, Iman F, Abdelhakam, Sara M, El Hadidy, Eman, Yousry, Rehab, El Dorry, Ahmed K
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2017
Assuntos:
Case Control Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5368624/
https://ncbi.nlm.nih.gov/pubmed/28396717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v9.i9.469
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados